(MIRABEGRON 25 ER + SOLIFENACIN 5 MG)
UROLOGY(MIRABEGRON 25 ER + SOLIFENACIN 5 MG)
UROLOGYMIRABAY S Tablet is typically prescribed for the following conditions:
1. Overactive bladder (OAB): It helps relieve symptoms such as urinary urgency, frequency, and urge incontinence.
MIRABAY S Tablet is a combination medication that contains two active ingredients: Mirabegron and Solifenacin.
Mirabegron is a beta-3 adrenergic receptor agonist that relaxes the detrusor muscle in the bladder. This action increases the bladder's capacity to hold urine and reduces the frequency and urgency of urination.
Solifenacin is an antimuscarinic medication that blocks the action of acetylcholine, a neurotransmitter that plays a role in bladder muscle contractions. By inhibiting acetylcholine, Solifenacin helps further reduce urinary urgency, frequency, and episodes of urge incontinence.
MIRABAY S Tablet is typically prescribed for the following conditions:
1. Overactive bladder (OAB): It helps relieve symptoms such as urinary urgency, frequency, and urge incontinence.
The dosage of MIRABAY S Tablet will vary depending on the specific condition being treated and the doctor's recommendations.
It is typically taken orally as an extended-release tablet, usually once daily with or without food.
Follow your healthcare provider's instructions regarding the dosage and administration.
MIRABAY S Tablet may cause side effects in some individuals. Common side effects may include:
1. Dry mouth
2. Increased blood pressure
3. Constipation
4. Blurred vision
5. Nasopharyngitis (inflammation of the nose and throat)
MIRABAY S Tablet should not be used in certain situations, including:
1. Hypersensitivity or allergy to Mirabegron, Solifenacin, or any other components of the medication.
2. Severe uncontrolled high blood pressure.
3. Urinary retention (inability to empty the bladder completely).
4. Gastric retention (delayed emptying of the stomach).
5. Certain eye conditions like narrow-angle glaucoma.
6. Severe liver impairment.